Professor Andrew Pollard of Oxford University told the BBC that though there have been no safety concerns found within the trial itself, the trial will be put on hold until regulators from the UK’s Medicine and Healthcare products Regulatory Agency (MHRA) have reviewed the blood clotting issue.
“Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial,” Prof Pollard said.
The suspension of the trial came in the wake of the head of vaccines for the EMA, Marco Cavaleri saying of the link between the vaccine and blood clotting: “In my opinion, we can now say it, it is clear there is an association with the vaccine. What causes this reaction, however, we still do not know.”
The European Medicines Agency, however, said that